Please fill in the form with your username, your password will be send to your registered e-mail.
* Mandatory fields
Website dedicated to help patients, their family and friends about the cancer immunotherapeutic approach in an easy-to-understand format.
Website providing information about the now recruiting Non-Small Cell Lung Cancer phase III clinical study
This section describes the main objective of ASCI. ASCI aims at educating the patients’ own immune system to fight the tumor.
This can be achieved by:
In the formulation of ASCI, antigen and Adjuvant Systems have been matched to maximize the quantity and quality of the immune response against the cancer antigens.
If this is your first time at this site, please click here to register.
Register now
For legal reasons, this page is intended solely for healthcare professionals. This is why we ask you to register.
© 2001 - 2008 GlaxoSmithKline plc. All rights reserved.